genetic sequence pangolin Covid-19 May 6, 2020


Chris Martenson asks why the Sars-CoV2 stands alone like a sore thumb?

If you have followed along Peak Prosperity and his Covd-19 research you will know he backs up his talks with research papers and his knowledge of this work.  As you are aware Fake News CNN won’t ask these questions…  And worse yet none of the mainstream except Newsweek has with asking more questions and of alternative non-mainstream narratives, you will find what appears to be lot’s of backpedaling and attempts at dismissing the notion that Sars-Cov-2 was created in a lab.  The defensive nature of Scientists whose paychecks for further dangerous “Gain-of-Function” research and monkeying around with a virus seem to be attacking anyone questioning the current nonsense of “it wasn’t created in a lab” by humans argument over and over. 

Why are these people writing all sorts of technical papers to cover their A$$?

Because no more money?

virology scientists prra

Are Scientists Lying to Us?

Complete video dissecting the mystery of Sars-CoV-2 and explained in Laymans terms by Chris Martenson of in a video titled “Are Scientists Lying to Us?”  Video Below with a discussion and referencing technical research articles written.


furin missing prra


Why did President Trumps administration shut down research being farmed out by @ecohealthnyc

Another question.  Looking into this NYC group who funds research and what looks like nobel philanthropic and humanitarian assistance around the world in developing countries on Ebola and other viruses.  Publicly available information abounds on Ecohealth Alliance on their IRS 990 forms.  No idea what ties they have to gain-of-function research but seems coincidental that the executive branch of the US Government shut down their funding.

What was being funded by EcoHealth Alliance anyway?  And why are they upset?  Why does a non-profit have a President drawing a $300,000?  Well that’s their business.  Just saying…

“There are more than 1.5 million unknown viruses lurking in the wild; around 500,000 have the potential to infect people and cause a global pandemic. EcoHealth Alliance is the only nonprofit working to discover and stop these diseases before they strike.- Ecohealth Alliance

https: // charity. org /success-stories/ecohealth-alliance-notes-field-nenneh-liberia

“Current infectious disease outbreaks are at their highest rates in history. Ecohealth Alliance is combating misinformation, fear and panic with state of the art science. We are cutting through the noise, going viral and connecting you to a healthier world… any pandemic is just one flight away from here.. we found live ebola virus in a bat in West Africa”

“At EcoHealth Alliance, we’re using cutting-edge science to create a world without pandemics, a world without panic. We believe in a world where people live in harmony with the wildlife and ecosystems around us. That’s our vision for the future. What’s yours? ”

2:16 Southeast China 2005, Wild Animal Markets
“..Shortly after the SARS outbreak, our scientist went to China to find out where it came from. We showed that it emerged in the Wild Animal Markets in South East China where bats and other animals became contaminated with this virus and eventually got into people. With this information, The Chinese Government has been able to act, to move into those markets and prevent the cycle of transmission there have been no known cases of SARS since, and that’s how to cut through all the noise “- Video Dated uploaded to Youtube on May 23, 2019.

Narrative above by Dr. Peter Daszak, President

Your Tax Dollars at work through NIH Funded projects by EcoHealth Alliance

Question is why is a separate agency funding work done in China?  Why does the NIH need an intermediary group ?

Project Number: 1R01AI110964-01 Contact PI / Project Leader: DASZAK, PETER

DESCRIPTION (provided by applicant): This project will examine the risk of future coronavirus (CoV) emergence from wildlife using in-depth field investigations across the human-wildlife interface in China, molecular characterization of novel CoVs and host receptor binding domain genes, mathematical models of transmission and evolution, and in vitro and in vivo laboratory studies of host range. Zoonotic CoVs are a significant threat to global health, as demonstrated with the emergence of pandemic severe acute respiratory syndrome coronavirus (SARS-CoV) in China in 2002, and the recent and ongoing emergence of Middle East Respiratory Syndrome (MERS-CoV). Bats appear to be the natural reservoir of these viruses, and hundreds of novel bat-CoVs have been discovered in the last two decades. Bats, and other wildlife species, are hunted, traded, butchered and consumed across Asia, creating a large scale human-wildlife interface, and high risk of future emergence of novel CoVs. This project aims to understand what factors increase the risk of the next CoV emerging in people by studying CoV diversity in a critical zoonotic reservoir (bats), at sites of high risk for emergence (wildlife markets) in an emerging disease hotspot (China). The three specific aims of this project are to: 1. Assess CoV spillover potential at high risk human-wildlife interfaces in China. This will include quantifying he nature and frequency of contact people have with bats and other wildlife; serological and molecular screening of people working in wet markets and highly exposed to wildlife; screening wild-caught and market sampled bats from 30+ species for CoVs using molecular assays; and genomic characterization and isolation of novel CoVs. 2. Develop predictive models of bat CoV emergence risk and host range. A combined modeling approach will include phylogenetic analyses of host receptors and novel CoV genes (including functional receptor binding domains); a fused ecological and evolutionary model to predict host-range and viral sharing; and mathematical matrix models to examine evolutionary and transmission dynamics. 3. Test predictions of CoV inter-species transmission. Predictive models of host range (i.e. emergence potential) will be tested experimentally using reverse genetics, pseudovirus and receptor binding assays, and virus infection experiments across a range of cell cultures from different species and humanized mice.

Here is a URL of the list of NIH funded studies being conducted and publicly available for review:

https: //projectreporter. nih. gov/project_info_description.cfm?aid=8674931&icde=49750546